Fig. 2From: Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuseRelevant features of the Geisinger translational research infrastructure and study design of GaPO that allow for large scale genomic and phenotypic data captureBack to article page